Lyme disease vaccine progressing into Phase I trials
by News Desk from Outbreak News Today on (#24SS7)
Lyon, France biotech firm, Valneva SE, announced Friday that its vaccine candidate VLA15 against Lyme disease is now progressing into clinical testing (Phase I) following the Investigational New Drug application (IND) clearance from the Food & Drug Administration (FDA) and the approval of the Clinical Trial Application (CTA) in Europe (Belgium). Currently, there is no licensed vaccine ["]
The post Lyme disease vaccine progressing into Phase I trials appeared first on Outbreak News Today.